ESAIC Academy

A phase 3 open label study of the sufentanil sublingual tablet 30 mcg for treatment of acute post-operative pain
ESAIC Academy. Minkowitz H. 06/03/17; 185350; 08AP01-6 Topic: Acute Pain Management
Harold Minkowitz
Harold Minkowitz
Login now to access Regular content available to all registered users.
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies